PINK1 and esophageal squamous cell carcinoma: In non-small-cell lung cancer (NSCLC), PINK1 downregulation potentiates cisplatin-induced NSCLC cell apoptosis [105,106], and similar results have been obtained in esophageal squamous cell carcinoma (ESCC) patients undergoing neoadjuvant chemotherapy [107].